Gloria Acquafredda

Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Therapeutic Magnetic Resonance (TMR) in Regenerative Medicine: In Vitro Study to Support Future Clinical Applications.

Therapeutic Magnetic Resonance (TMR) in Regenerative Medicine: In Vitro Study to Support Future Clinical Applications.

Journal: Journal of functional biomaterials

Published: May 21, 2026

Second Allogeneic Hematopoietic Cell Transplantation After Graft Failure Is an Effective Curative Option in Children With Hemoglobinopathies.

Second Allogeneic Hematopoietic Cell Transplantation After Graft Failure Is an Effective Curative Option in Children With Hemoglobinopathies.

Journal: American journal of hematology

Published: January 21, 2026

Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation.

Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation.

Journal: Microorganisms

Published: November 11, 2024

Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile.

Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile.

Journal: Cells

Published: December 15, 2023

Production of donor-derived cytotoxic T lymphocytes with potent anti-leukemia activity for adoptive immunotherapy in high-risk pediatric patients given haploidentical hematopoietic stem cell transplantation.

Production of donor-derived cytotoxic T lymphocytes with potent anti-leukemia activity for adoptive immunotherapy in high-risk pediatric patients given haploidentical hematopoietic stem cell transplantation.

Journal: Cytotherapy

Published: September 20, 2023

New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs.

New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs.

Journal: Pharmacological research

Published: February 24, 2023

Mesenchymal Stromal Cell on Liver Decellularised Extracellular Matrix for Tissue Engineering.

Mesenchymal Stromal Cell on Liver Decellularised Extracellular Matrix for Tissue Engineering.

Journal: Biomedicines

Published: September 20, 2022

Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies.

Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies.

Journal: American journal of hematology

Published: March 02, 2022

Proliferation Pattern of Pediatric Tumor-Derived Mesenchymal Stromal Cells and Role in Cancer Dormancy: A Perspective of Study for Surgical Strategy.

Proliferation Pattern of Pediatric Tumor-Derived Mesenchymal Stromal Cells and Role in Cancer Dormancy: A Perspective of Study for Surgical Strategy.

Journal: Frontiers in pediatrics

Published: August 29, 2021

MKRN3 and KISS1R mutations in precocious and early puberty.

MKRN3 and KISS1R mutations in precocious and early puberty.

Journal: Italian journal of pediatrics

Published: November 28, 2019

Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA-associated respiratory failure in the pediatric setting.

Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA-associated respiratory failure in the pediatric setting.

Journal: Pediatric pulmonology

Published: April 29, 2019

Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.

Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.

Journal: Cytotherapy

Published: January 08, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026